Peer-reviewed veterinary case report
New horse antibody treatment quickly lowers venom in dog, cat, horse
By Carotenuto, Sarah E et al.·Published in Journal of veterinary emergency and critical care (San Antonio, Tex. : 2001)·2026·Emergency Veterinarian, United States·View original on PubMed →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: A Novel Equine F[ab']Veterinary Antivenom for North American Viperid Snake Envenomation Demonstrates Efficacy by Rapid Serum Venom Removal and Improvement in Snakebite Severity Score.
Plain-English summary
A group of 22 dogs, one cat, and one horse that were bitten by venomous snakes received a new antivenom treatment. Most of the pets showed a significant improvement, with 94.4% having a strong response to the antivenom, which rapidly reduced the venom in their systems by over 90%. The severity of their symptoms improved significantly within just a few hours after treatment. This new antivenom appears to be effective in treating snakebites in pets, helping them recover quickly from the effects of the venom.
People also search for: dog snakebite treatment · cat snake venom recovery · horse antivenom effectiveness
Abstract
OBJECTIVE: To assess the efficacy of a new equine F[ab']antivenom (US Department of Agriculture code 6101.05) in removing serum venom and lowering the snakebite severity score (SSS) in animals suffering from naturally occurring viperid envenomation. DESIGN: Retrospective study, April 2020 to October 2021. SETTING: Veterinary hospitals across four North American regions. ANIMALS: Twenty-two dogs, one cat, and one horse. INTERVENTIONS: All patients received the new antivenom intravenously and were assessed for clinical response. Most dogs required one vial for clinical control of signs. MEASUREMENTS AND MAIN RESULTS: Among the dogs and cats with detectable initial serum venom, 94.4% showed a strong response to antivenom administration, with a reduction in serum venom ranging from 94% to >99% at 2 h. Animals that experienced a 90% reduction of serum venom within 2 h greatly exceeded the 0% expected of an ineffective antivenom. The canine and feline SSS improved relative to the initial SSS at 2, 6, and 12 h in 57.9%, 77.8%, and 90.9% of cases, respectively. A favorable reduction in SSS was also appreciated in the single horse in the study. CONCLUSIONS: In the canine, feline, and equine cases of North American viperid envenomation studied, antivenom 6101.05 adequately removed serum venom and lowered the SSS.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/41582890/